History of Impirica
We are constantly learning, evolving and advancing as an organization, and we know the focused efforts of yesterday have given us the confidence to tackle the challenges of today and the opportunities presented tomorrow. From our start in a research lab 25 years ago to now we have the foundation to help our customers.
Receive approval to commence a 5 year research collaboration with the University of Alberta with a single mission of establishing a deeper understanding of impairment measurement.
Release our first peer reviewed research paper relating to our mobile cognitive screen (CARE).
Complete our first version of the law enforcement specific pocket field sobriety test, ready for piloting with partnering agencies. View our Law Enforcement page for more information.
Initiate our in-house data science department to leverage the power of machine learning and AI on our 130,000 real world assessments and in the way we will analyze tests in the future.
Establish a formal relationship with Canadian-based cannabis license producers to develop impairment measurements for medical cannabis users.
Included in research project looking at cannabis impairment, cognition & driving at the University of Colorado.
Commence development on our law enforcement specific pocket field sobriety test.
Begin working with Canadian law enforcement agencies in closed studies, running our mobile cognitive test alongside a DRE screen to establish correlation and predictability.
Included in second largest research project in North America looking at cannabis impairment and driving at the University of Colorado.
Invited to present to the Canadian federal task force for the legalization of cannabis and the Colorado task force for drunk & impaired driving, discussing the approach of embracing mobilized cognitive science to actively measure impairment.
Initiate research on the effects of cannabis and cognition to identify impairment.
Commence the journey to mobilize our science with mobile App technology.
Edmonton Transit Service ask question about how to fairly and effectively screen commercial drivers.
North American validation study completed comprised of population of 1540. Provides our solution for the medically at risk market.
The company with a mission to create safer communities through the fusion of science and technology is founded.
University of Alberta research commences under the leadership of Dr. Allen Dobbs.
University of Alberta hospital asks the question about fair screening of medically- at-risk drivers.